Sort by
Refine Your Search
-
Category
-
Program
-
Field
-
Respiratory Viruses Division (CORVD), National Center for Immunization and Respiratory Diseases (NCIRD), CDC. You will receive training in advanced molecular methods, next-generation sequencing (NGS), viral
-
. This project contributes to Infectious Disease Pathology Brach (IDPB)’s molecular pathology program by applying molecular and sequencing-based methods to detect a broad range of pathogens in fixed tissues. Under
-
, reducing agricultural productivity, grain quality, and food and feed safety. The research will integrate genome sequences, genetic variation, transcriptomic profiles, functional annotations, protein
-
assays for malaria and other parasitic diseases such as Babesiosis and Chagas disease. A major part of the project involves next generation sequencing (NGS) including use of the Oxford Nanopore Technology
-
to characterize the structure and function of plant, insect, and fungal genomes related to pecan cultivar development. Application of sequence resources from plants, pests, and pathogens will be directed towards
-
dynamics of Salmonella within pasture-based poultry production systems by integrating phenotypic characterization, whole-genome sequencing, and transcriptomic profiling. By advancing the understanding
-
this opportunity is the characterization of honey bee viromes through Next Generation Sequencing technologies (NGS) to uncover previously undescribed viral and other microbial threats to bee health. This unique
-
communities, testing dietary and other control modalities, as part of the learning experience. This will include various culture methods, nucleic acid extraction, PCR methods, sequence analysis
-
professionals. Under the guidance of a CDC mentor, you may: Analyze respiratory virus sequence data and associated surveillance metadata; Gain experience preparing routine and ad hoc genomic surveillance reports
-
of diverse PRRSV strains causing extreme pathogenesis and disease. Transcriptomics datasets have been generated via bulk and single-cell RNA sequencing from blood and disease-affected tissues and will be